Evidence map›Paper›PMID 35754473›Full record

ArticleFrontiers in pharmacology2022

A 4/8 Subtype α-Conotoxin Vt1.27 Inhibits N-Type Calcium Channels With Potent Anti-Allodynic Effect.

Shuo Wang, Peter Bartels, Cong Zhao, Arsalan Yousuf, Zhuguo Liu, Shuo Yu, Anuja R Bony, Xiaoli Ma, Qin Dai, Ting Sun and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Shuo WangBeijing Institute of Biotechnology, Beijing, China.
Peter BartelsIllawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia.
Cong ZhaoDepartment of Chemistry, Renmin University of China, Beijing, China.
Arsalan YousufIllawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia.
Zhuguo LiuBeijing Institute of Biotechnology, Beijing, China.
Shuo YuBeijing Institute of Biotechnology, Beijing, China.
Anuja R BonyIllawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia.
Xiaoli MaBeijing Institute of Biotechnology, Beijing, China.
Qin DaiBeijing Institute of Biotechnology, Beijing, China.
Ting SunBeijing Institute of Biotechnology, Beijing, China.
Na LiuBeijing Institute of Biotechnology, Beijing, China.
Mengke YangSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Rilei YuSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Weihong DuDepartment of Chemistry, Renmin University of China, Beijing, China.
David J AdamsIllawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia.
Qiuyun DaiBeijing Institute of Biotechnology, Beijing, China.
University of Wollongong · AUOcean University of China · CNRenmin University of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel 4/8 subtype α-conotoxin, Vt1.27 (NCCMFHTCPIDYSRFNC-NH

Indexed as

anti-allodynic effectConus vitulinuselectrophysiologynicotinic acethylcholine receptorN-type calcium channelsα-conotoxin Vt1.27

Identifiers

PMID35754473
PMCPMC9230573
OpenAlexW4225139369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.